1 Supplementary information Mechanism of IRSp53 inhibition by 14 - 3 - 3 David J . Kast 1 , 2 and Roberto Dominguez 1 1 Department of Physiology , Perelman School of Medicine , University of Pennsylvania , Philadelphia , PA 19104 , USA 2 Current address : Department of Cell Biology and Physiology , Washington University , St . Louis , MO 63110 , USA ORCID : DK , 0000 - 0002 - 1031 - 1211 ORCID : RD , 0000 - 0003 - 3186 - 5229 Correspondence and requests for materials should be addressed to R . D . ( email : droberto @ pennmedicine . upenn . edu ) 2 Supplementary Table 1 : Synthetic IRSp53 phospho - peptides Peptide Sequence Site 1 319 AQPKSL ( pS ) PPQSQS 331 Site 2 333 LSDSYSN ( pT ) LPVRKS 346 Site 3 354 ATTENK ( pT ) LPRSSS 366 Site 4 360 TLPRSS ( pS ) MAAGLEK 373 Site 5 448 QQGKSS ( pS ) TGNLLD 460 Sites 1 , 2 319 AQPKSL ( pS ) PPQSQSKLSDSYSN ( pT ) LPVRKS 346 Sites 2 , 3 335 SDSYSN ( pT ) LPVRKSVTPKNSYATTENK ( pT ) LPRSSS 366 Sites 2 , 4 335 SDSYSN ( pT ) LPVRKSVTPKNSYATTENKTLPRSS ( pS ) MAAGLE 372 3 Supplementary Table 2 : Crystallographic data and refinement statistics Structure Site 2 ( pT340 ) Site 3 ( pT360 ) Site 4 ( pS366 ) Sites 2 , 3 ( pT340 / pT360 ) Sites 3 , 4 ( pT340 / pS366 ) Data collection Beamline NSLS X6A MacCHESS A1 X8 Prospector X8 Prospector X8 Prospector Wavelength ( Å ) 1 . 000 0 . 977 1 . 540 1 . 540 1 . 540 Space group P 1 P 1 P 1 P 1 P 21 21 21 Cell a , b , c ( Å ) Cell α , β , γ ( ° ) 60 . 0 , 69 . 1 , 84 . 6 105 . 3 , 95 . 7 , 115 . 0 59 . 4 , 68 . 6 , 84 . 8 72 . 9 , 85 . 6 , 64 . 7 59 . 9 , 69 . 3 , 84 . 7 106 . 1 , 95 . 6 , 114 . 9 61 . 1 , 69 . 6 , 150 . 5 99 . 2 , 93 . 0 116 . 0 69 . 9 , 75 . 0 , 100 . 2 90 . 0 , 90 . 0 , 90 . 0 Resolution ( Å ) 31 . 3 – 2 . 0 ( 2 . 06 – 2 . 0 ) a 21 . 9 – 2 . 3 ( 2 . 38 – 2 . 3 ) 29 . 4 – 2 . 35 ( 2 . 4 – 2 . 35 ) 43 . 0 – 2 . 8 ( 2 . 9 – 2 . 8 ) 60 . 0 – 2 . 9 ( 3 . 0 – 2 . 9 ) R merge ( % ) 4 . 2 ( 37 . 9 ) 8 . 7 ( 57 . 9 ) 5 . 8 ( 20 . 5 ) 14 . 2 ( 29 . 3 ) 27 . 8 ( 34 . 4 ) I / σ I 21 . 8 ( 3 . 5 ) 12 . 5 ( 3 . 6 ) 20 . 0 ( 4 . 9 ) 20 . 5 ( 2 . 5 ) 17 . 0 ( 2 . 1 ) No . unique reflections 76071 ( 6527 ) 49462 ( 4819 ) 45896 ( 4330 ) 51911 ( 5197 ) 12087 ( 1064 ) Multiplicity 3 . 4 ( 2 . 7 ) 3 . 6 ( 3 . 2 ) 5 . 5 ( 2 . 7 ) 4 . 8 ( 2 . 1 ) 7 . 2 ( 1 . 9 ) Completeness ( % ) 95 . 7 ( 92 . 0 ) 96 . 6 ( 94 . 3 ) 95 . 6 ( 90 . 4 ) 96 . 7 ( 95 . 7 ) 98 . 8 ( 91 . 4 ) CC 1 / 2 0 . 999 ( 0 . 888 ) 0 . 996 ( 0 . 87 ) 0 . 998 ( 0 . 889 ) 0 . 975 ( 0 . 717 ) 0 . 887 ( 0 . 629 ) Wilson B - factor ( Å 2 ) 32 . 75 35 . 95 23 . 21 30 . 91 25 . 61 Refinement Resolution ( Å ) 31 . 3 – 2 . 0 21 . 9 – 2 . 3 29 . 4 – 2 . 35 43 . 0 – 2 . 8 60 . 0 – 2 . 9 No . reflections 76054 49428 45857 51490 12042 R work ( % ) / R free ( % ) 19 . 5 / 22 . 9 19 . 2 / 22 . 2 21 . 2 / 25 . 1 23 . 5 / 28 . 6 21 . 5 / 25 . 8 No . atoms Protein Ligands Solvent ( H 2 O ) 7868 92 517 7763 111 110 7692 70 406 15360 212 93 3868 50 34 RMS deviations Bond lengths ( Å ) Bond angles ( ° ) 0 . 003 0 . 55 0 . 002 0 . 46 0 . 002 0 . 45 0 . 005 0 . 62 0 . 004 0 . 88 B - factors ( Å 2 ) Protein Ligand Solvent 42 . 2 52 . 4 42 . 6 54 . 0 60 . 9 43 . 0 31 . 7 40 . 6 29 . 9 38 . 3 46 . 5 18 . 5 22 . 5 34 . 5 14 . 6 Ramachandran ( % ) Favored Outliers 99 . 1 0 . 0 98 . 6 0 . 0 98 . 9 0 . 0 97 . 3 0 . 0 98 . 3 0 . 0 PDB code 6BCR 6BCY 6BD1 6BQT 6BD2 a Values in parentheses are for highest - resolution shell 4 Supplementary Table 3 : Oligonucleotide sequences Constructs Sequence IRSp53 Primer : pEGFP - C1 : NheI - IRSp53 - FLAG ( Δ GFP ) , Forward GGTGCTAGCATGTCTCTGTCTCGCTCAGAGG Primer : pEGFP - C1 : IRSp53 - FLAG - SalI ( Δ GFP ) 1 of 2 , Reverse CGTCATCGTCCTTGTAGTCTCCGDYKDDDCACTGTGCACACCAGCGTG Primer : pEGFP - C1 : IRSp53 - FLAG - SalI ( Δ GFP ) 2 of 2 , Reverse ACCGTCGACCTACTTGTCGTCATCGTCCTTGTAGTCTCC Primer : pEGFP - C1 : IRSp53 - STREP - SalI ( Δ GFP ) 1 of 2 , Reverse CTGAGGGTGGGACCAGCC CACTGTGGACACCAGCGTG Primer : pEGFP - C1 : IRSp53 - STREP - SalI ( Δ GFP ) 2 of 2 , Reverse ACCGTCGACTCACTTCTCGAACTGAGGGTGGGACCAGCC Primer : pIRES 1 : NheI - IRSp53 - FLAG , Forward GGTGCTAGCATGTCTCTGTCTCGCTCAGAGG Primer : pIRES 1 : IRSp53 - FLAG - EcoRI 1 of 2 , Reverse CGTCATCGTCCTTGTAGTCTCCGDYKDDDCACTGTGCACACCAGCGTG Primer : pIRES 1 : IRSp53 - FLAG - EcoRI 2 of 2 , Reverse ACCGAATTC CTACTTGTCGTCATCGTCCTTGTAGTC Primer : pIRES 2 : SalI - IRSp53 - STREP , Forward GGTGTCGACATGTCTCTGTCTCGCTCAGAGG Primer : pIRES 2 : IRSp53 - STREP - NotI 1 of 2 , Reverse CTGAGGGTGGGACCAGCC CACTGTGGACACCAGCGTG Primer : pIRES 2 : IRSp53 - STREP - NotI 2 of 2 , Reverse ACCGCGGCCGC TCACTTCTCGAACTGAGGGTGG Mutations of the phosphorylation sites of IRSp53 QuickChange Primer : pEGFP Site 2 Mutation ( T340A ) , Forward CGACTCCTACTCCAACGCACTCCCCGTGCGCAAGAGC QuickChange Primer : pEGFP Site 2 Mutation ( T340A ) , Reverse GCTCTTGCGCACGGGGAGTGCGTTGGA GTAGGAGTCG QuickChange Primer : pEGFP Site 3 Mutation ( T360A ) , Forward GCCACCACCGAGAACAAGGCTCTGCCTCGCTCGAGC QuickChange Primer : pEGFP Site 3 Mutation ( T360A ) , Reverse GCTCGAGCGAGGCAGAGCCTTGTTCTCGGTGGTGGC QuickChange Primer : pEGFP Site 4 Mutation ( S366A ) , Forward GCCTCGCTCGAGCGCCATGGCAGCCGGCCTGG QuickChange Primer : pEGFP Site 4 Mutation ( S366A ) , Reverse CCAGGCCGGCTGCCATGGCGCTCGAGCGAGGC Primer pEGFP Site 5 Mutation ( 452 SSST 455 to 452 AAAA 455 ) , Forward GCCGCCGCCGCCGGCAACCTCCTGGA CAAGG Primer : pEGFP Site 5 Mutation ( 452 SSST 455 to 452 AAAA 455 ) , Reverse GGCGGCGGCGGCCTTCCCTTGCTGCAGGCTC 5 Supplementary Table 3 , continued : Oligonucleotide sequences Constructs Sequence Eps8 Primer : pEGFP - C1 : NheI 2xFLAG Eps8 ( Δ GFP ) 1 of 3 , Forward CGACAAGGGAATGAATGGTCATATTTCTAATCATCCCAG Primer : pEGFP - C1 : NheI 2xFLAG Eps8 ( Δ GFP ) 2 of 3 , Forward GGACGATGACGACAAGGGAATGAATGGTCATATTTC Primer : pEGFP - C1 : NheI 2xFLAG Eps8 ( Δ GFP ) 1 of 3 , Forward ATGGGAGACTACAAGGACGATGACGACAAGGGA Primer : pEGFP - C1 : 2xFLAG Eps8 ( Δ GFP ) SalI , Reverse GGTGTCGACTTAGTGACTGCTTCCTTCATCAAAAGATT 14 - 3 - 3 Primer : pTYB11 : SapI - 14 - 3 - 3 , Forward GGTTGCTCTTCCAACATGGAGAAGACTGAGCTGATCCAG Primer : pTYB11 : 14 - 3 - 3 - PstI , Reverse GGTCTGCAGTCATTAGTTTTCAGCCCCTTCTGCC Primer : pMal - c2e : EcoRI - TEV - 14 - 3 - 3 1 of 2 Forward CCTGTATTTTCAGTCTATGGAGAAGACTGAGCTGATCCAG Primer : pMal - c2e : EcoRI - TEV - 14 - 3 - 3 2 of 2 , Forward GGTGAATTCGAAAACCTGTATTTTCAGTCTATGGAGAAGACTGA Primer : pMal - c2e : 14 - 3 - 3 - SalI , Reverse GGTGTCGACTTAGTTTTCAGCCCCTTCTGCC 6 Supplementary Fig . 1 : Representative MS / MS spectra of the five reproducibly phosphorylation sites found in pIRSp53 . The phosphorylation site ( bold characters ) , y - ( blue ) and b - ion ( red ) series are indicated on the peptide sequences . The localization probabilities of the assigned phosphorylation sites were validated using the Ascore algorithm ( see Methods ) . b3 b2 y1 y3 y4 y5 y6 S S pS366 M A A G L E R y7 S L pS325 P P Q S Q S K S S pS454 T G N L L D K b1 b2 y1 y2 y3 y4 y5 y6 y7 Site 1 Site 2 Site 4 Ascore : 21 . 95 Localization Probability : 98 . 7 % Ascore : 23 . 2 Localization Probability : 99 . 1 % Site 5 N S Y A T T E N K pT360 L P R y1 y2 y3 b3 b2 b1 y6 b4 b5 y8 y9 y10 Ascore : 17 . 99 Localization Probability : 96 . 9 % Ascore : 24 . 95 Localization Probability : 99 . 7 % Ascore : 44 . 63 Localization Probability : 100 . 0 % Site 3 L S D S Y S N pT340 L P V R K y1 y3 y4 y5 y2 b3 b2 b4 y7 y8 b2 y1 y4 y5 y6 y7 y2 b2 Supplementary Fig . 1 7 Supplementary Fig . 2 : Synthetic singly - and doubly - phosphorylated peptides of IRSp53 . The purity of each peptide was confirmed using HPLC ( left panels ) and their masses were validated using MALDI - TOF mass spectrometry ( right panels ) . In each case the measured mass was nearly identical to the theoretical mass of the phosphorylated peptides . 574 . 0 1026 . 6 1479 . 2 1931 . 8 2384 . 4 2837 . 0 Mass ( m / z ) % I n t en s i t y 100 80 90 70 60 50 40 30 20 10 0 1097 . 0 1469 . 28 Da 0 . 0 19 . 9 Retention Time ( min ) 10 . 430 2398 . 0 3242 . 2 4086 . 4 4930 . 6 5774 . 8 6619 . 0 Mass ( m / z ) % I n t en s i t y 100 80 90 70 60 50 40 30 20 10 0 1383 . 0 4264 . 08 Da 334 Ac - SDSYSNpTLPVRKSVTPKNSYATTENKTLPRSSpSMAAGLER - NH 2 373 0 . 0 19 . 9 Retention Time ( min ) 0 . 0 19 . 9 Retention Time ( min ) 644 . 0 1038 . 0 1432 . 0 1826 . 0 2220 . 0 2614 . 0 Mass ( m / z ) % I n t en s i t y 100 80 90 70 60 50 40 30 20 10 0 1469 . 28 Da 0 . 0 19 . 9 Retention Time ( min ) 10 . 521 831 . 0 1196 . 2 1561 . 4 1926 . 6 2291 . 8 2657 . 0 Mass ( m / z ) % I n t en s i t y 100 80 90 70 60 50 40 30 20 10 0 1127 . 0 1569 . 85 Da 0 . 0 19 . 9 Retention Time ( min ) 9 . 020 334 Ac - SDSYSNpTLPVRKSVTPKNSYATTENKpTLPRSSS - NH 2 366 360 Ac - TLPRSSpSMAAGLEK - NH 2373 354 Ac - ATTENKpTLPRSSS - NH 2366 0 . 0 19 . 9 Retention Time ( min ) 10 . 466 797 . 0 1209 . 8 1622 . 6 2035 . 4 2448 . 2 2861 . 0 Mass ( m / z ) % I n t en s i t y 100 80 90 70 60 50 40 30 20 10 0 1383 . 0 333 Ac - LSDSYSNpTLPVRKS - NH 2346 2812 . 0 3192 . 4 3572 . 8 3953 . 2 4333 . 6 4714 . 0 Mass ( m / z ) % I n t en s i t y 100 80 90 70 60 50 40 30 20 10 0 Site 2 Site 3 Site 4 Site 5 Sites 2 , 3 Sites 2 , 4 3479 . 9 3732 . 57 Da 10 . 025 10 . 230 477 . 0 1690 . 54 Da 448 Ac - QQGKSSpSTGNLLD - NH 2460 Expected Mass : 1688 Da Expected Mass : 1471 Da Expected Mass : 1569 Da Expected Mass : 1456 Da Expected Mass : 3732 Da Expected Mass : 4260 Da 8 Supplementary Fig . 3 : 14 - 3 - 3 does not bind to phosphomimetic mutants of IRSp53 . ITC titrations of 200 µ M 14 - 3 - 3 θ into 20 µ M E . coli - expressed IRSp53 carrying S / T to D or E mutations of phosphorylation sites 2 , 3 , 4 and 5 ( as indicated ) . Experiments were performed at 20°C . Systematic heat differences were not observed ( indicating lack of binding ) and thus the titrations could not be fitted . 0 . 0 0 . 5 1 . 0 1 . 5 2 . 0 2 . 5 - 0 . 35 - 0 . 30 - 0 . 25 - 0 . 20 - 0 . 15 - 0 . 10 - 0 . 05 0 . 00 - 0 . 025 - 0 . 020 - 0 . 015 - 0 . 010 - 0 . 005 0 . 000 0 . 005 0 . 010 0 . 015 0 . 020 0 20 40 60 80 100 120 140 160 Time ( min ) ! " # $ % & ’ " Molar Ratio ( " # $ % ) * $ ’ + * , + - . / ’ " 0 # . 0 0 . 00 0 . 05 0 . 10 0 . 15 0 . 20 0 . 25 - 0 . 10 - 0 . 08 - 0 . 06 - 0 . 04 - 0 . 02 0 . 00 0 . 02 - 0 . 020 - 0 . 015 - 0 . 010 - 0 . 005 0 . 000 0 . 005 0 . 010 0 20 40 60 80 100 120 140 160 Time ( min ) ! " # $ % & ’ " Molar Ratio ( " # $ % ) * $ ’ + * , + - . / ’ " 0 # . 0 14 - 3 - 3 θ IRSp53 ( T340D / T360D / S366D / S454D ) 0 0 . 5 1 1 . 5 2 2 . 5 0 0 . 5 1 1 . 5 2 2 . 5 Molar Ratio Molar Ratio kc a l / m o l µ c a l / s e c 0 - 0 . 015 0 . 010 - 0 . 06 0 - 0 . 08 - 0 . 10 - 0 . 04 - 0 . 02 0 . 02 - 0 . 010 - 0 . 005 0 . 005 - 0 . 10 0 . 020 0 0 - 0 . 30 - 0 . 20 - 0 . 020 - 0 . 010 0 . 010 Time ( min ) 0 40 120 160 80 0 40 120 160 80 Time ( min ) No Binding No Binding Supplementary Fig . 3 14 - 3 - 3 θ IRSp53 ( T340E / T360E / S366E / S454E ) kc a l / m o l µ c a l / s e c 9 Supplementary Fig . 4 : WT / mutant IRSp53 heterodimers do not form when co - expressed using two different plasmids . a Illustration of the unsuccessful strategy used to co - express WT / mutant IRSp53 heterodimers in HEK293T cells using two separate plasmids and two different affinity tags ( IRSp53 - FLAG and M2345 - STREP ) . The IRSp53 mutant ( M2345 ) carries mutations at site 2 ( T340A ) , site 3 ( T360A ) , site 4 ( S366A ) and site 5 ( S452A - S453A - S454A - T455A ) . b While this strategy did not produce heterodimers , the results were nonetheless informative since endogenous 14 - 3 - 3 only bound to WT IRSp53 , as illustrated by the amounts of 14 - 3 - 3 that coimmunoprecipitates with IRSp53 after affinity purification through two consecutive affinity columns , independent of the order of the purification . The results also demonstrate that IRSp53 does not form heterodimers when expressed from two separate plasmids , and thus IRSp53 dimerization must occur during translation and once formed the dimers never dissociate . a Relative 14 - 3 - 3 amount IRSp53 14 - 3 - 3 L E F STREP ( 1st ) F E FLAG ( 2nd ) 1 . 0 0 . 5 0 . 0 L E F F E Purification tag ( step ) FLAG ( 1st ) STREP ( 2nd ) Co - IP analysis of WT IRSp53 - FLAG and mutant M2345 - STREP using two separate plasmids ( IRSp53 WT and M2345 do not form heterodimers ) L – Load F – Flowthrough E – Elution Strep - Tactin resin Anti - FLAG resin L E F E F L E F E F Coexpression of WT IRSp53 - FLAG and mutant M2345 - STREP using two separate plasmids b STREP ✖ ✖ FLAG WT IRSp53 - FLAG M2345 - STREP Supplementary Fig . 4 M2345 - STREP ( T340A / T360A / S366A / 452 SSST 455 - > AAAA ) WT IRSp53 - FLAG 14 - 3 - 3 θ 58 32 58 32 kDa kDa 10 Supplementary Fig . 5 : Structures of complexes of 14 - 3 - 3 θ with singly - phosphorylated IRSp53 peptides . a - c Complexes of 14 - 3 - 3 θ with the Site 2 , Site 3 and Site 4 peptides of IRSp53 , showing the overall structure ( left ) and close - ups of one of the binding pockets of 14 - 3 - 3 θ ( right ) , including the experimentally observed regions of the peptides and the corresponding 2F o - F c electron density maps contoured at 1 σ . Note that in the case of singly - phosphorylated peptides , both pockets of 14 - 3 - 3 θ bind the same peptide in a pseudo - symmetric manner . In the sequence diagrams shown , the regions of the peptides observed in the structures are highlighted bold , the phosphorylation sites are highlighted red , and the portions of the peptide unresolved in the structures are shown in gray . Site 2 Site 4 a b c 340 SDSYSNpTLPVRKS 360 ATTENKpTLPRSSS Site 3 TLPRSSpSMAAGLER 366 K345 R344 T356 S365 T356 S365 R344 R344 Y337 S365 T356 R363 G370 R363 G370 G370 R363 pT340 pT360 pS366 Y337 E357 Y337 Supplementary Fig . 5 K345 K345 P342 Unoccupied portion of the 14 - 3 - 3 θ groove P362 A368 11 Supplementary Fig . 6 : Stereo images of the peptide - binding pocket of 14 - 3 - 3 θ showing the electron density map for the singly - phosphorylated peptides . a - c Complexes of 14 - 3 - 3 θ with the Site 2 , Site 3 and Site 4 peptides of IRSp53 , showing the 2F o - F c electron density maps contoured at 1 σ . In the sequence diagrams , the regions of the peptides observed in the structures are highlighted bold , the phosphorylation sites are highlighted red , and the portions of the peptide unresolved in the electron density maps are shown in gray . Site 2 340 SDSYSNpTLPVRKS a b 360 ATTENKpTLPRSSS Site 3 Site 4 c TLPRSSpSMAAGLER 366 Supplementary Fig . 6 12 Supplementary Fig . 7 : Stereo images of the peptide - binding pockets of 14 - 3 - 3 θ showing the electron density map for the doubly - phosphorylated peptides . a - b Complexes of 14 - 3 - 3 θ with the Sites 2 , 3 and Sites 2 , 4 peptides of IRSp53 , showing the 2F o - F c electron density maps contoured at 1 σ . In the sequence diagrams , the regions of the peptides observed in the structures are highlighted bold , the phosphorylation sites are highlighted red , and the portions of the peptide unresolved in the electron density maps are shown in gray . Sites 2 , 3 340 334 SDSYSNTLPVRKSVTPKNSYATTENKTLPRSSS 366 360 340 334 SDSYSNTLPVRKSVTPKNSYATTENKTLPRSSSMAAGLER 373 Sites 2 , 4 366 a b pT340 pT360 pT340 pS366 Supplementary Fig . 7 13 Supplementary Fig . 8 : Proteins used in this study . Coomassie - stained SDS - PAGE illustrating the purity of several of the proteins used in this study : pIRSp53 , Eps8 , 14 - 3 - 3 θ and Cdc42 ( G12V ) . pIRSp53 and Eps8 were expressed in mammalian cells , whereas 14 - 3 - 3 θ and Cdc42 were expressed in E . coli . ( see Methods ) . pIRSp53 Eps8 75 58 46 32 25 kDa 14 - 3 - 3 θ ( monomer ) Cdc42 22 100 135 190 17 14 - 3 - 3 θ ( dimer ) Supplementary Fig . 8 SDS - PAGE 14 Supplementary Fig . 9 : Original polyacrylamide gels and western blots . Red boxes mark the regions of the polyacrylamide gels or western blots that were used in the indicated Figs and Supplementary Figures . Lysates 0 2 4 24 Serum starvation time , h IRSp53 14 - 3 - 3 0 2 4 24 32 25 58 FLAG Elution kDa 75 Fig . 1a 32 25 75 58 kDa Fig . 1b ( bottom ) IRSp53 14 - 3 - 3 Doubly - phos . peptide FLAG peptide Flow through Input Fig . 1c ( left , SDS - PAGE ) Doubly - phos . peptide FLAG peptide 58 75 32 25 46 100 kDa 20 Flow through Input 75 58 kDa Fig . 1c ( right , ProQ diamond ) 100 Doubly - phos . peptide FLAG peptide Flow through Input beads 32 25 75 58 kDa Serum Starved IRSp53 14 - 3 - 3 2 3 4 5 23 24 234 WT 2345 WT IRSp53 32 25 75 58 kDa 2nd Elution Beads after 2 nd Elution Fig . 3b ( top ) Fig . 3b ( bottom ) IRSp53 14 - 3 - 3 FLAG STREP 2345 2345 WT WT WT 2345 2345 WT 2345 2345 WT WT WT 2345 2345 WT 2345 2345 WT WT WT 2345 2345 WT 75 58 kDa 75 58 WT FLAG STREP WT 2345 2345 WT / WT 2345 2345 WT / Fig . 3a and 3b Fig . 2f Fig . 1a - c 15 Supplementary Fig . 9 , continued : Original polyacrylamide gels and western blots . FLAG Elution Beads anti - Flag magnetic beads + + + + + + FLAG - Eps8 / p - IRSp53 / 14 - 3 - 3 + + p - IRSp53 / 14 - 3 - 3 / FLAG - Eps8 + + 14 - 3 - 3 + + IRSp53 14 - 3 - 3 32 25 58 75 kDa 46 Fig . 5f Fig . 6a L E1 F STREP ( 1st ) FLAG ( 2nd ) Purification tag ( step ) E2 E3 E4 E1 F E2 E3 E4 14 - 3 - 3 32 25 IRSp53 58 75 L E1 F STREP ( 2nd ) FLAG ( 1st ) Purification tag ( step ) E2 E3 E4 E1 F E2 E3 E4 14 - 3 - 3 32 25 IRSp53 58 75 kDa kDa Supplementary Fig . 3f 58 75 32 25 46 100 p - IRSp53 Eps8 kDa 14 - 3 - 3 Cdc42 14 - 3 - 3 ( dimer ) 20 135 190 IRSp53 - FLAG Anion Exchange High Salt Input Supplementary Fig . 2c C IRSp53 - FLAG M234 - FLAG M C M C M C M 2 0 0 2 Starvation time ( h ) pan - 14 - 3 - 3 Actin GAPDH IRSp53 E - cadherin Actin kDa 58 25 100 58 32 32 135 75 32 75